Status:

COMPLETED

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Lead Sponsor:

Complejo Hospitalario Xeral-Calde

Collaborating Sponsors:

LEO Pharma

Conditions:

Acute Pulmonary Embolism

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the feasibility of the long-term treatment of pulmonary embolism with tinzaparin compared to oral anticoagulants.

Detailed Description

The open-label prospective randomized clinical trial compares subcutaneous LMWH (tinzaparin) administered for 6 months versus initial treatment using subcutaneous LMWH followed by oral anticoagulants ...

Eligibility Criteria

Inclusion

  • Symptomatic pulmonary embolism patients confirmed by:
  • High probability ventilation/perfusion lung scan according to the PIOPED criteria
  • Spiral chest computed tomography, or
  • Pulmonary arteriography
  • Aged 18 years or above, of either sex
  • The patient must provide signed informed consent
  • Patients will be agreed for receiving ambulatory anticoagulant treatment

Exclusion

  • Massive pulmonary embolism
  • Allergy to heparin, other components of Tinzaparin or acenocoumarol
  • Previous thrombocytopenia induced by heparin
  • Thrombocytopenia \< 100000/mm3
  • History/signs/symptoms of congenital bleeding disorder
  • Life expectancy less than 90 days
  • Unfractioned heparin anticoagulation for more than 36 hours prior enrollment
  • Inability to participate in the home tinzaparin program
  • Clinical overt gastrointestinal blood loss due to peptic ulcer, intestinal tumours, oesophagitis or diverticulosis
  • Hemoglobin lower than 7 g/dL or Creatinin \> 3mg/dL
  • Cerebral-vascular accident
  • Cerebral, medullary and ophthalmological surgery

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2009

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT00711308

Start Date

April 1 2005

End Date

February 1 2009

Last Update

February 13 2009

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Pneumology Service. Hospital Clínico

Santiago de Compostela, A Coruña, Spain, 15706

2

Pneumology Service

Lugo, Lugo, Spain, 27004

3

Pneumology Service. Hospital Xeral Cies

Vigo, Pontevedra, Spain, 36204

4

Pneumology Service. Hospital do Meixoeiro

Vigo, Pontevedra, Spain, 36214

Tinzaparin in the Treatment of the Acute Pulmonary Embolism | DecenTrialz